High-flow nasal cannula versus noninvasive ventilation for postextubation acute respiratory failure after pediatric cardiac surgery

Naohiro Shioji, Tomoyuki Kanazawa, Tatsuo Iwasaki, Kazuyoshi Shimizu, Tomohiko Suemori, Yasutoshi Kuroe, Hiroshi Morimatsu

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

We compared the reintubation rate in children who received high-flow nasal cannula (HFNC) therapy to the rate in children who received noninvasive ventilation (NIV) therapy for acute respiratory failure (ARF) after cardiac surgery. This was a retrospective analysis of 35 children who received HFNC therapy for ARF after cardiac surgery in 2014-2015 (the HFNC group). We selected 35 children who had received NIV therapy for ARF after cardiac surgery in 2009-2012 as a control group. The matching parameters were body weight and risk adjustment for congenital heart surgery category 1. The reintubation rate within 48 h in the HFNC group tended to be lower than that in the NIV group (3% vs. 17%, p=0.06). The reintubation rate within 28 days was significantly lower in the HFNC group compared to the NIV group (3% vs. 26%, p=0.04). The HFNC group's ICU stays were significantly shorter than those of the NIV group: 10 (IQR: 7-17) days vs. 17 (11-32) days, p=0.009. HFNC therapy might be associated with a reduced reintubation rate in children with ARF after cardiac surgery.

Original languageEnglish
Pages (from-to)15-20
Number of pages6
JournalActa medica Okayama
Volume73
Issue number1
Publication statusPublished - 2019

Keywords

  • Acute respiratory failure
  • Congenital heart disease
  • High-flow nasal cannula
  • Noninvasive ventilation
  • Reintubation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'High-flow nasal cannula versus noninvasive ventilation for postextubation acute respiratory failure after pediatric cardiac surgery'. Together they form a unique fingerprint.

Cite this